Innoviva (INVA) Shareholder's Equity Growth (1y) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 107.40% |
| Dec 31, 2025 | 69.69% |
| Sep 30, 2025 | 51.07% |
| Jun 30, 2025 | 7.41% |
| Mar 31, 2025 | -8.07% |
| Dec 31, 2024 | 2.40% |
| Sep 30, 2024 | 6.54% |
| Jun 30, 2024 | 19.89% |
| Mar 31, 2024 | 25.32% |
| Dec 31, 2023 | 19.29% |
| Sep 30, 2023 | -2.16% |
| Jun 30, 2023 | -1.83% |
| Mar 31, 2023 | 1.68% |
| Dec 31, 2022 | 7.58% |
| Sep 30, 2022 | 30.41% |
| Jun 30, 2022 | 43.61% |
| Mar 31, 2022 | -20.74% |
| Dec 31, 2021 | -13.47% |
| Sep 30, 2021 | -8.05% |
| Jun 30, 2021 | -20.10% |
| Mar 31, 2021 | 71.65% |
| Dec 31, 2020 | 77.67% |
| Sep 30, 2020 | 88.49% |
| Jun 30, 2020 | 99.76% |
| Mar 31, 2020 | 102.99% |
| Dec 31, 2019 | 115.10% |
| Sep 30, 2019 | 362.07% |
| Jun 30, 2019 | 258.79% |
| Mar 31, 2019 | 193.98% |
| Dec 31, 2018 | 165.53% |
| Sep 30, 2018 | 51.44% |
| Jun 30, 2018 | 47.64% |
| Mar 31, 2018 | 36.34% |
| Dec 31, 2017 | 31.24% |
| Sep 30, 2017 | 39.39% |
| Jun 30, 2017 | 18.28% |
| Mar 31, 2017 | 7.68% |
| Dec 31, 2016 | -3.02% |
| Sep 30, 2016 | -13.89% |
| Jun 30, 2016 | -23.51% |
| Mar 31, 2016 | -39.14% |
| Dec 31, 2015 | -53.41% |
| Sep 30, 2015 | -67.24% |
| Jun 30, 2015 | -56.77% |
| Mar 31, 2015 | -198.82% |
| Dec 31, 2014 | -174.67% |
| Sep 30, 2014 | -158.52% |
| Jun 30, 2014 | -318.95% |
| Mar 31, 2014 | 187.67% |
| Dec 31, 2013 | 92.95% |
| Sep 30, 2013 | 90.46% |
| Jun 30, 2013 | -54.75% |
| Mar 31, 2013 | 1,392.60% |
| Dec 31, 2012 | 278.09% |
| Sep 30, 2012 | 392.95% |
| Jun 30, 2012 | 604.93% |
| Dec 31, 2011 | -288.28% |
| Dec 31, 2010 | 88.14% |